Astellas Pharma Inc
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Astellas Pharma Inc is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Astellas Pharma Inc in the same report. This provides an indication of potential competitors or associated to Astellas Pharma Inc. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2016

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2016


2016-12-21
GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2016" provides an overview of Dry (Atrophic) Macular Degeneration clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4021CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC4021CTIDB
  • View Report: Research and Experts Market Report: Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016

    Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016


    2016-12-21
    GlobalData's clinical trial report, “Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Vernal Keratoconjunctivitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4007CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC4007CTIDB
  • View Report: Research and Experts Market Report: Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016

    Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct’s, ‘Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 1 Receptor Associated Kinase 4 (Renal...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0717TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0717TDB
  • View Report: Research and Experts Market Report: Vitiligo Global Clinical Trials Review, H2, 2016

    Vitiligo Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, H2, 2016" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3999CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3999CTIDB
  • View Report: Research and Experts Market Report: Dermatitis Global Clinical Trials Review, H2, 2016

    Dermatitis Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3997CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3997CTIDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis Global Clinical Trials Review, H2, 2016

    Atopic Dermatitis Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H2, 2016" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3995CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3995CTIDB
  • View Report: Research and Experts Market Report: Genital Herpes Global Clinical Trials Review, H2, 2016

    Genital Herpes Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H2, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3992CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3992CTIDB
  • View Report: Research and Experts Market Report: Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2016

    Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Herpes Zoster (Shingles) Global Clinical Trials Review, H2, 2016" provides an overview of Herpes Zoster (Shingles) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3987CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3987CTIDB
  • View Report: Research and Experts Market Report: High-Grade Glioma - Pipeline Review, H2 2016

    High-Grade Glioma - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma – Pipeline Review, H2 2016, provides an overview of the High-Grade Glioma (Oncology) pipeline landscape.

    High­ly gra­de glio­mas...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8917IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8917IDB
  • View Report: Research and Experts Market Report: Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016

    Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tinea pedis (Athlete Foot) – Pipeline Review, H2 2016, provides an overview of the Tinea pedis (Athlete Foot) (Infectious Disease) pipeline landscape.

    Athlete's...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8894IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8894IDB
  • View Report: Research and Experts Market Report: Heart Transplant Rejection - Pipeline Review, H2 2016

    Heart Transplant Rejection - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection – Pipeline Review, H2 2016, provides an overview of the Heart Transplant Rejection (Immunology) pipeline landscape.

    Heart transplantation...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8886IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8886IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016

    Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3950CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3950CTIDB
  • View Report: Research and Experts Market Report: Diarrhea Global Clinical Trials Review, H2, 2016

    Diarrhea Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H2, 2016" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3946CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3946CTIDB
  • View Report: Research and Experts Market Report: Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2016

    Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2016" provides an overview of Functional (Non Ulcer) Dyspepsia clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3937CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3937CTIDB
  • View Report: Research and Experts Market Report: Infectious Diarrhea Global Clinical Trials Review, H2, 2016

    Infectious Diarrhea Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H2, 2016" provides an overview of Infectious Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3933CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3933CTIDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H2 2016

    Breast Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Breast Cancer – Pipeline Review, H2 2016, provides an overview of the Breast Cancer (Oncology) pipeline landscape.

    Breast cancer is a cancer that develops from...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8871IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8871IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Peptic Ulcers - Pipeline Review, H2 2016

    Peptic Ulcers - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peptic Ulcers – Pipeline Review, H2 2016, provides an overview of the Peptic Ulcers (Gastrointestinal) pipeline landscape.

    Peptic ulcers are open sores that...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8842IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8842IDB
  • View Report: Research and Experts Market Report: Rhino-Conjunctivitis - Pipeline Review, H2 2016

    Rhino-Conjunctivitis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhino-Conjunctivitis – Pipeline Review, H2 2016, provides an overview of the Rhino-Conjunctivitis (Ophthalmology) pipeline landscape.

    Rhinitis is characterized...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8840IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8840IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) – Pipeline Review, H2 2016, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape.

    Retinit...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8828IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8828IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Enterocolitis Global Clinical Trials Review, H2, 2016

    Enterocolitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H2, 2016" provides an overview of Enterocolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Enterocolitis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3902CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3902CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H2, 2016

    Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3887CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3887CTIDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H2, 2016

    Venous Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3886CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3886CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H2, 2016

    Atrial Flutter Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3883CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3883CTIDB
  • View Report: Research and Experts Market Report: Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016

    Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3881CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3881CTIDB
  • View Report: Research and Experts Market Report: Bone Metastasis Global Clinical Trials Review, H2, 2016

    Bone Metastasis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H2, 2016" provides an overview of Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3880CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3880CTIDB
  • View Report: Research and Experts Market Report: Salivary Gland Cancer Global Clinical Trials Review, H2, 2016

    Salivary Gland Cancer Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Salivary Gland Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3878CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3878CTIDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0672TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0672TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0670TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0670TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Huntington Disease - Pipeline Review, H2 2016

    Huntington Disease - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease – Pipeline Review, H2 2016, provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape.

    Huntington's...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8805IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8805IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H2 2016

    Age Related Macular Degeneration - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration – Pipeline Review, H2 2016, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape.

    Age...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8804IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8804IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Proteinuria Global Clinical Trials Review, H2, 2016

    Proteinuria Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Proteinuria Global Clinical Trials Review, H2, 2016" provides an overview of Proteinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Proteinuria. Report...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3872CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3872CTIDB
  • View Report: Research and Experts Market Report: Renal Stones/Calculi Global Clinical Trials Review, H2, 2016

    Renal Stones/Calculi Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2016" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3860CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3860CTIDB
  • View Report: Research and Experts Market Report: Renal Failure Global Clinical Trials Review, H2, 2016

    Renal Failure Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2016" provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure....
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3859CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3859CTIDB
  • View Report: Research and Experts Market Report: Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review,...

    Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016’, provides in depth analysis on Human cytomegalovirus 65 kDa Phosphoprotein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0623TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0623TDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016

    Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2016, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) (Oncology) pipeline landscape.

    Mu...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8715IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8715IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Industry Report: Biotechnology in Asia-Pacific

    Biotechnology in Asia-Pacific


    2016-11-25
    Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Biotechnology
  • Asia Pacific
  • $350.00
  • Report 05IK-OHME8009 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME8009
  • View Report: Research and Experts Industry Report: Biotechnology in Japan

    Biotechnology in Japan


    2016-11-23
    Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Japan
  • $350.00
  • Report 05IK-OHME7987 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME7987
  • View Report: Research and Experts Market Report: Dyspepsia Global Clinical Trials Review, H2, 2016

    Dyspepsia Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, H2, 2016" provides an overview of Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspepsia. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3835CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3835CTIDB
  • View Report: Research and Experts Project Profile: Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report

    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report


    2016-12-23
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions,...
  • Project Profile
  • Life Sciences
  • Japan
  • $175.00
  • Report 05IK-E67F3102-8EEA-4380-A487-21 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-E67F3102-8EEA-4380-A487-21
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016

    Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.) - Pipeline Review, H2 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0603TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0603TDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H2 2016

    Migraine - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine – Pipeline Review, H2 2016, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

    Migraine is a disorder characterized...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8702IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8702IDB
  • View Report: Research and Experts Market Report: Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

    Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline Review, H2 2016, provides an overview of the Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline landscape....
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8694IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8694IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8687IDB
  • View Report: Research and Experts Market Report: Lung Transplant Rejection Global Clinical Trials Review, H2, 2016

    Lung Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Lung Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Lung Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3825CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3825CTIDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016

    Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Bone Marrow Transplant Rejection clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3823CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3823CTIDB
  • View Report: Research and Experts Market Report: Heart Transplant Rejection Global Clinical Trials Review, H2, 2016

    Heart Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Heart Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3822CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3822CTIDB
  • View Report: Research and Experts Market Report: Liver Transplant Rejection Global Clinical Trials Review, H2, 2016

    Liver Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Liver Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Liver Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3821CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3821CTIDB
  • View Report: Research and Experts Market Report: Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

    Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3820CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3820CTIDB
  • View Report: Research and Experts Market Report: Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family...

    Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0593TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0593TDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2016, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8770IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8770IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016

    Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dry (Atrophic) Macular Degeneration – Pipeline Review, H2 2016, provides an overview of the Dry (Atrophic) Macular Degeneration (Ophthalmology) pipeline landscape.

    D...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8675IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8675IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8673IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8673IDB
  • View Report: Research and Experts Market Report: Aspergillosis - Pipeline Review, H2 2016

    Aspergillosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis – Pipeline Review, H2 2016, provides an overview of the Aspergillosis (Infectious Disease) pipeline landscape.

    Aspergillosis is an infection or...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8668IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8668IDB
  • View Report: Research and Experts Market Report: Ewing Sarcoma - Pipeline Review, H2 2016

    Ewing Sarcoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma – Pipeline Review, H2 2016, provides an overview of the Ewing Sarcoma (Oncology) pipeline landscape.

    Ewing's sarcoma is a primary bone cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8657IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8657IDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome - Pipeline Review, H2 2016

    Irritable Bowel Syndrome - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome – Pipeline Review, H2 2016, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.

    Inflammatory...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8649IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8649IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3813CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3813CTIDB
  • View Report: Research and Experts Market Report: Dermatomyositis Global Clinical Trials Review, H2, 2016

    Dermatomyositis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Dermatomyositis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatomyositis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatomyositis...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3806CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3806CTIDB
  • View Report: Research and Experts Market Report: Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016

    Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016" provides an overview of Focal Segmental Glomerulosclerosis (FSGS) clinical trials scenario. This report provides top...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3803CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3803CTIDB
  • View Report: Research and Experts Market Report: Myopia Global Clinical Trials Review, H2, 2016

    Myopia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H2, 2016" provides an overview of Myopia clinical trials scenario. This report provides top line data relating to the clinical trials on Myopia. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3801CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3801CTIDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

    Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016" provides an overview of Secondary Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3792CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3792CTIDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H2 2016

    Schizophrenia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

    Schizophrenia is a chronic,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8727IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8727IDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H2 2016

    Anaplastic Astrocytoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma – Pipeline Review, H2 2016, provides an overview of the Anaplastic Astrocytoma (Oncology) pipeline landscape.

    Anaplastic astrocytoma...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8632IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8632IDB
  • View Report: Research and Experts Market Report: Hairy Cell Leukemia - Pipeline Review, H2 2016

    Hairy Cell Leukemia - Pipeline Review, H2 2016


    2016-10-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia – Pipeline Review, H2 2016, provides an overview of the Hairy Cell Leukemia (Oncology) pipeline landscape.

    Hairy cell leukemia is a rare,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8630IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8630IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: Restless Legs Syndrome Global Clinical Trials Review, H2, 2016

    Restless Legs Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Restless Legs Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3787CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3787CTIDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia Global Clinical Trials Review, H2, 2016

    Postherpetic Neuralgia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, H2, 2016" provides an overview of Postherpetic Neuralgia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3782CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3782CTIDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2016

    Osteoarthritis Pain - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain – Pipeline Review, H2 2016, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.

    Osteoarthritis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8600IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8600IDB
  • View Report: Research and Experts Market Report: Peanut Allergy - Pipeline Review, H2 2016

    Peanut Allergy - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy – Pipeline Review, H2 2016, provides an overview of the Peanut Allergy (Immunology) pipeline landscape.

    Peanut allergy is common, especially...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8594IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8594IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Kidney Transplant Rejection - Pipeline Review, H2 2016

    Kidney Transplant Rejection - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Transplant Rejection – Pipeline Review, H2 2016, provides an overview of the Kidney Transplant Rejection (Immunology) pipeline landscape.

    Kidney transplantati...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8539IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8539IDB
  • View Report: Research and Experts Market Report: Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016

    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2016, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) (Genito...
  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8538IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8538IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H2 2016

    Overactive Bladder - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder – Pipeline Review, H2 2016, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.

    Overactive...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8530IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8530IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory)...
  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8528IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8528IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H2 2016

    Uveitis - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis – Pipeline Review, H2 2016, provides an overview of the Uveitis (Ophthalmology) pipeline landscape.

    Uveitis is swelling and irritation of the uvea,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8544IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8544IDB
  • View Report: Research and Experts Market Report: Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016

    Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2016" provides an overview of Oropharyngeal Candidiasis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3774CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3774CTIDB
  • View Report: Research and Experts Market Report: Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016

    Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016" provides an overview of Pneumocystis carinii Pneumonia clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3762CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3762CTIDB
  • View Report: Research and Experts Market Report: Mycoses Global Clinical Trials Review, H2, 2016

    Mycoses Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Mycoses Global Clinical Trials Review, H2, 2016" provides an overview of Mycoses clinical trials scenario. This report provides top line data relating to the clinical trials on Mycoses. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3761CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3761CTIDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation Global Clinical Trials Review, H2, 2016

    Atrial Fibrillation Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Fibrillation clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3754CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3754CTIDB
  • View Report: Research and Experts Market Report: Urinary Incontinence Global Clinical Trials Review, H2, 2016

    Urinary Incontinence Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Urinary Incontinence Global Clinical Trials Review, H2, 2016" provides an overview of Urinary Incontinence clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3748CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3748CTIDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis Global Clinical Trials Review, H2, 2016

    Ulcerative Colitis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3742CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3742CTIDB
  • View Report: Research and Experts Market Report: Endometriosis Global Clinical Trials Review, H2, 2016

    Endometriosis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, H2, 2016" provides an overview of Endometriosis clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3741CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3741CTIDB
  • View Report: Research and Experts Market Report: Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016

    Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016" provides an overview of Benign Prostatic Hyperplasia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3740CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3740CTIDB
  • View Report: Research and Experts Market Report: Liver Transplant Rejection - Pipeline Review, H2 2016

    Liver Transplant Rejection - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Liver Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Liver Transplant Rejection pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8508IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8508IDB
  • View Report: Research and Experts Market Report: Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8501IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8501IDB
  • View Report: Research and Experts Market Report: Hypersensitivity - Pipeline Review, H2 2016

    Hypersensitivity - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypersensitivity,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8499IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8499IDB
  • View Report: Research and Experts Market Report: Herpes Zoster (Shingles) - Pipeline Review, H2 2016

    Herpes Zoster (Shingles) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H2 2016’, provides an overview of the Herpes Zoster (Shingles) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8493IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8493IDB
  • View Report: Research and Experts Market Report: Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016

    Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2016’, provides an overview of the Varicella Zoster (HHV-3) Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8492IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8492IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2016

    Lupus Nephritis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8490IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8490IDB
  • View Report: Research and Experts Market Report: Cedar Pollen Allergy - Pipeline Review, H2 2016

    Cedar Pollen Allergy - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Cedar Pollen Allergy - Pipeline Review, H2 2016’, provides an overview of the Cedar Pollen Allergy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cedar...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8489IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8489IDB
  • View Report: Research and Experts Market Report: Ependymoma Global Clinical Trials Review, H2, 2016

    Ependymoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Ependymoma Global Clinical Trials Review, H2, 2016" provides an overview of Ependymoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ependymoma. Report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3736CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3736CTIDB
  • View Report: Research and Experts Market Report: Febrile Neutropenia Global Clinical Trials Review, H2, 2016

    Febrile Neutropenia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2016" provides an overview of Febrile Neutropenia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3704CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3704CTIDB
  • View Report: Research and Experts Market Report: Aplastic Anemia Global Clinical Trials Review, H2, 2016

    Aplastic Anemia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Aplastic Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Aplastic Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Aplastic...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3703CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3703CTIDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Current and Future Players

    Prostate Cancer - Current and Future Players


    2015-04-08
    GlobalData has released its pharma report, “Prostate Cancer - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prostate Cancer Market. The report...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1060FPR has a star rating of 3.8 out of 5
  • Go to More information on Report 05IC-GDHC1060FPR
  • View Report: Research and Experts Market Report: Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016

    Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0516TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0516TDB
  • View Report: Research and Experts Market Report: Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

    Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016’, provides in depth analysis on Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0515TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0515TDB
  • View Report: Research and Experts Market Report: Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase...

    Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein Kinase 2a or MAPK14 or EC 2.7.11.24)


    2016-09-14
    Global Markets Direct’s, ‘Mitogen Activated Protein Kinase 14 (Cytokine Suppressive Anti Inflammatory Drug Binding Protein or Mitogen Activated Protein Kinase p38 Alpha or MAP Kinase MXI2 or MAX Interacting Protein 2 or Stress Activated Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0514TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0514TDB
  • View Report: Research and Experts Market Report: Gastric Ulcers - Pipeline Review, H2 2016

    Gastric Ulcers - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Gastric Ulcers - Pipeline Review, H2 2016’, provides an overview of the Gastric Ulcers pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Ulcers,...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8458IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8458IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H2 2016

    Endometriosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2016’, provides an overview of the Endometriosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometriosis,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8457IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8457IDB
  • View Report: Research and Experts Market Report: Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2016

    Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2016’, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8448IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8448IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2016

    Arterial Thrombosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8444IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8444IDB
  • View Report: Research and Experts Market Report: Visceral Pain - Pipeline Review, H2 2016

    Visceral Pain - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H2 2016’, provides an overview of the Visceral Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Visceral Pain,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8432IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8432IDB
  • View Report: Research and Experts Market Report: Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016

    Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016’, provides in depth analysis on Human Cytomegalovirus Envelope Glycoprotein B (gB) targeted pipeline therapeutics.

    The report provides...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0500TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0500TDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H2 2016

    Epilepsy - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2016’, provides an overview of the Epilepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8401IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8401IDB
  • View Report: Research and Experts Market Report: Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016

    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016’, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8396IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8396IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H2 2016

    Osteoarthritis - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8387IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8387IDB
  • View Report: Research and Experts Market Report: cAMP and cAMP Inhibited cGMP 3

    cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016’, provides in depth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0459TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0459TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Ligand Superfamily Member 11 (Receptor Activator Of Nuclear Factor Kappa B Ligand or Osteoclast Differentiation...

    Tumor Necrosis Factor Ligand Superfamily Member 11 (Receptor Activator Of Nuclear Factor Kappa B Ligand or Osteoclast Differentiation Factor or TNF Related Activation Induced Cytokine or Osteoprotegerin Ligand or CD254 or TNFSF11) - Pipeline Review, H2 20


    2016-08-10
    Global Markets Direct’s, ‘Tumor Necrosis Factor Ligand Superfamily Member 11 (Receptor Activator Of Nuclear Factor Kappa B Ligand or Osteoclast Differentiation Factor or TNF Related Activation Induced Cytokine or Osteoprotegerin Ligand or CD254...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0457TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0457TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8355IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8355IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016

    Diabetic Nephropathy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8347IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8347IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2016

    Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2016’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8336IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8336IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Current and Future Players

    Atopic Dermatitis - Current and Future Players


    2015-11-03
    GlobalData has released its pharma report, “Atopic Dermatitis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Atopic Dermatitis Market. The...
  • Market Report
  • Dermatology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1050FPR has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC1050FPR
  • View Report: Research and Experts Market Report: Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016

    Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3599CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3599CTIDB
  • View Report: Research and Experts Market Report: Arterial Stiffness Global Clinical Trials Review, H2, 2016

    Arterial Stiffness Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arterial Stiffness Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3589CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3589CTIDB
  • View Report: Research and Experts Market Report: Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H2, 2016

    Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H2, 2016" provides an overview of Spinal Muscular Atrophy (SMA) clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3562CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3562CTIDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016

    Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3555CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3555CTIDB
  • View Report: Research and Experts Market Report: Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016

    Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016


    2016-07-27
    ‘Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H2 2016’, provides in depth analysis on Beta Nerve Growth Factor (Beta NGF or NGF) targeted pipeline therapeutics.

    The report provides comprehensive information on the Beta Nerve...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0413TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0413TDB
  • View Report: Research and Experts Market Report: High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein...

    High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline


    2016-07-27
    ‘High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) -...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0410TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0410TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0401TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0401TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0399TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0399TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

    Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0398TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0398TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) targeted pipeline therapeutics.

    The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0396TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0396TDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2016

    Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2016


    2016-07-20
    ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2016’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8296IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8296IDB
  • View Report: Research and Experts Market Report: Diabetic Macular Edema - Pipeline Review, H2 2016

    Diabetic Macular Edema - Pipeline Review, H2 2016


    2016-07-20
    ‘Diabetic Macular Edema - Pipeline Review, H2 2016’, provides an overview of the Diabetic Macular Edema pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic Macular Edema, complete...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8286IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8286IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H2 2016

    Constipation - Pipeline Review, H2 2016


    2016-07-20
    ‘Constipation - Pipeline Review, H2 2016’, provides an overview of the Constipation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Constipation, complete with analysis by stage of...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8299IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8299IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2016

    Diabetic Neuropathic Pain - Pipeline Review, H2 2016


    2016-07-27
    ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8307IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8307IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016


    2016-07-20
    ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8297IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8297IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H2 2016

    Fibromyalgia - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibromyalgia - Pipeline Review, H2 2016’, provides an overview of the Fibromyalgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fibromyalgia, complete with analysis by stage of...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8279IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8279IDB
  • View Report: Research and Experts Market Report: Urinary Incontinence - Pipeline Review, H2 2016

    Urinary Incontinence - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H2 2016’, provides an overview of the Urinary Incontinence pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Urinary...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8272IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8272IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H2 2016

    Sepsis - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H2 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8220IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8220IDB
  • View Report: Research and Experts Market Report: Nocturia - Pipeline Review, H2 2016

    Nocturia - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Nocturia - Pipeline Review, H2 2016’, provides an overview of the Nocturia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Nocturia, complete with analysis...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8229IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8229IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain Global Clinical Trials Review, H1, 2016

    Neuropathic Pain Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Neuropathic Pain. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3528CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3528CTIDB
  • View Report: Research and Experts Market Report: 65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016

    65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016’, provides in depth analysis on 65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0311TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0311TDB
  • View Report: Research and Experts Market Report: Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline...

    Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Macrophage Stimulating Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0265TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0265TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0228TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0228TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0225TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0225TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016

    Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Glucocorticoid-Induced Osteoporosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3508CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3508CTIDB
  • View Report: Research and Experts Market Report: Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016

    Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Peripheral Neuropathy clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3503CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3503CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Huntington

    OpportunityAnalyzer: Huntington's Disease - Opportunity Analysis and Forecast to 2024


    2016-05-03
    Huntington’s Disease (HD) is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired motor control, cognitive dysfunction, behavioral changes, and mood disorders. Approved treatments for HD across the 7MM are extremely limited,...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC056POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC056POA
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016

    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016" provides an overview of Adrenocortical Carcinoma (Adrenal Cortex Cancer) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3493CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3493CTIDB
  • View Report: Research and Experts Market Report: Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone-Sensitive Prostate Cancer clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3483CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3483CTIDB
  • View Report: Research and Experts Market Report: Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

    Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016’, provides in depth analysis on Gamma Secretase (EC 3.4.23.46) targeted pipeline therapeutics.

    The report provides comprehensive information on the Gamma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0117TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0117TDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3478CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3478CTIDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathy Global Clinical Trials Review, H1, 2016

    Diabetic Neuropathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3434CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3434CTIDB
  • View Report: Research and Experts Market Report: Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family...

    Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review,...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0098TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0098TDB
  • View Report: Research and Experts Market Report: Peptic Ulcers - Pipeline Review, H1 2016

    Peptic Ulcers - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Peptic Ulcers - Pipeline Review, H1 2016’, provides an overview of the Peptic Ulcers pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Peptic Ulcers,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8193IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8193IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2016

    Multiple Sclerosis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Multiple...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7962IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7962IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8168IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8168IDB
  • View Report: Research and Experts Market Report: Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

    Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Herpes Simplex Virus (HSV) Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8166IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8166IDB
  • View Report: Research and Experts Market Report: Huntington Disease - Pipeline Review, H1 2016

    Huntington Disease - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Huntington Disease - Pipeline Review, H1 2016’, provides an overview of the Huntington Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Huntington...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8162IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8162IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H1 2016

    Age Related Macular Degeneration - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related Macular Degeneration pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7973IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7973IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

    Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7967IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7967IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Laryngeal Cancer Global Clinical Trials Review, H1, 2016

    Laryngeal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Laryngeal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3395CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3395CTIDB
  • View Report: Research and Experts Market Report: Hyperparathyroidism Global Clinical Trials Review, H1, 2016

    Hyperparathyroidism Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H1, 2016" provides an overview of Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3391CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3391CTIDB
  • View Report: Research and Experts Market Report: Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016

    Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H1 2016’, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8100IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8100IDB
  • View Report: Research and Experts Market Report: Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2016

    Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2016’, provides an overview of the Cytomegalovirus (HHV-5) Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8009IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8009IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2016

    Migraine - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2016’, provides an overview of the Migraine pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Migraine, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8006IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8006IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome - Pipeline Review, H1 2016

    Irritable Bowel Syndrome - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2016’, provides an overview of the Irritable Bowel Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8036IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8036IDB
  • View Report: Research and Experts Market Report: Ewing Sarcoma - Pipeline Review, H1 2016

    Ewing Sarcoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2016’, provides an overview of the Ewing Sarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ewing Sarcoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8034IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8034IDB
  • View Report: Research and Experts Market Report: Aspergillosis - Pipeline Review, H1 2016

    Aspergillosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H1 2016’, provides an overview of the Aspergillosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Aspergillosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8030IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8030IDB
  • View Report: Research and Experts Market Report: Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2016

    Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Dry (Atrophic) Macular Degeneration pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8027IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8027IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8019IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8019IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8017IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8017IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Hairy Cell Leukemia - Pipeline Review, H1 2016

    Hairy Cell Leukemia - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H1 2016’, provides an overview of the Hairy Cell Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hairy...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8051IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8051IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Myasthenia Gravis Global Clinical Trials Review, H1, 2016

    Myasthenia Gravis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2016" provides an overview of Myasthenia Gravis clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3375CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3375CTIDB
  • View Report: Research and Experts Market Report: Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016

    Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3374CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3374CTIDB
  • View Report: Research and Experts Market Report: Low Back Pain - Pipeline Review, H1 2016

    Low Back Pain - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H1 2016’, provides an overview of the Low Back Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Low Back Pain,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8044IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8044IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

    Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0002TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0002TDB
  • View Report: Research and Experts Market Report: Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

    Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016’, provides in depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0001TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0001TDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2016

    Osteoarthritis Pain - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7825IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7825IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2016

    Asthma - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7683IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7683IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016

    Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016" provides an overview of Cytomegalovirus (HHV-5) Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3361CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3361CTIDB
  • View Report: Research and Experts Market Report: Hyponatremia Global Clinical Trials Review, H1, 2016

    Hyponatremia Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Hyponatremia Global Clinical Trials Review, H1, 2016" provides an overview of Hyponatremia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyponatremia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3354CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3354CTIDB
  • View Report: Research and Experts Market Report: Endocarditis Global Clinical Trials Review, H1, 2016

    Endocarditis Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Endocarditis Global Clinical Trials Review, H1, 2016" provides an overview of Endocarditis clinical trials scenario. This report provides top line data relating to the clinical trials on Endocarditis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3332CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3332CTIDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H1 2016

    Overactive Bladder - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2016’, provides an overview of the Overactive Bladder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Overactive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7835IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7835IDB
  • View Report: Research and Experts Market Report: Kidney Transplantation - Pipeline Review, H1 2016

    Kidney Transplantation - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Kidney Transplantation - Pipeline Review, H1 2016’, provides an overview of the Kidney Transplantation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7832IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7832IDB
  • View Report: Research and Experts Market Report: Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016

    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2016’, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7828IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7828IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H1 2016

    Uveitis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2016’, provides an overview of the Uveitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7827IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7827IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7688IDB
  • View Report: Research and Experts Market Report: Liver Transplantation - Pipeline Review, H1 2016

    Liver Transplantation - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Liver Transplantation - Pipeline Review, H1 2016’, provides an overview of the Liver Transplantation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7906IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7906IDB
  • View Report: Research and Experts Market Report: Herpes Zoster (Shingles) - Pipeline Review, H1 2016

    Herpes Zoster (Shingles) - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H1 2016’, provides an overview of the Herpes Zoster (Shingles) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7897IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7897IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2016

    Lupus Nephritis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7856IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7856IDB
  • View Report: Research and Experts Market Report: Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2016

    Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2016’, provides an overview of the Varicella Zoster (HHV-3) Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7855IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7855IDB
  • View Report: Research and Experts Market Report: Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7848IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7848IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2016

    Chronic Pain - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7690IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7690IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Glaucoma - Pipeline Review, H1 2016

    Glaucoma - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H1 2016’, provides an overview of the Glaucoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7695IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7695IDB
  • View Report: Research and Experts Market Report: Gastric Ulcers - Pipeline Review, H1 2016

    Gastric Ulcers - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Gastric Ulcers - Pipeline Review, H1 2016’, provides an overview of the Gastric Ulcers pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Ulcers,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7778IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7778IDB
  • View Report: Research and Experts Market Report: Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2016

    Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2016’, provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7747IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7747IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2016

    Arterial Thrombosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7739IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7739IDB
  • View Report: Research and Experts Market Report: Visceral Pain - Pipeline Review, H1 2016

    Visceral Pain - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H1 2016’, provides an overview of the Visceral Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Visceral Pain,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7727IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7727IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H1 2016

    Endometriosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2016’, provides an overview of the Endometriosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometriosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7713IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7713IDB
  • View Report: Research and Experts Market Report: Vitiligo Global Clinical Trials Review, H1, 2016

    Vitiligo Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Vitiligo Global Clinical Trials Review, H1, 2016" provides an overview of Vitiligo clinical trials scenario. This report provides top line data relating to the clinical trials on Vitiligo. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3314CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3314CTIDB
  • View Report: Research and Experts Market Report: Lupus Nephritis Global Clinical Trials Review, H1, 2016

    Lupus Nephritis Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2016" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3304CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3304CTIDB
  • View Report: Research and Experts Industry Report: Astellas Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Astellas Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Biotechnology
  • Japan
  • $350.00
  • Report 05IK-1B12707F-F397-42C4-9529-F5 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-1B12707F-F397-42C4-9529-F5
  • View Report: Research and Experts Industry Report: Biotechnology in Japan

    Biotechnology in Japan


    2015-02-12
    Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Japan
  • $350.00
  • Report 05IK-OHEC3238 has a star rating of 3.5 out of 5
  • Go to More information on Report 05IK-OHEC3238
  • View Report: Research and Experts Industry Report: Biotechnology in Asia-Pacific

    Biotechnology in Asia-Pacific


    2015-02-12
    Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Biotechnology
  • Asia Pacific
  • $350.00
  • Report 05IK-OHEC3230 has a star rating of 3.4 out of 5
  • Go to More information on Report 05IK-OHEC3230
  • View Report: Research and Experts Industry Report: Pharmaceuticals in Asia-Pacific

    Pharmaceuticals in Asia-Pacific


    2015-12-11
    Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players...
  • Industry Report
  • Pharmaceuticals
  • Asia Pacific
  • $350.00
  • Report 05IK-OHME5099 has a star rating of 4.1 out of 5
  • Go to More information on Report 05IK-OHME5099
  • View Report: Research and Experts Industry Report: Pharmaceuticals in Singapore

    Pharmaceuticals in Singapore


    2015-12-11
    Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players...
  • Industry Report
  • Pharmaceuticals
  • Singapore
  • $350.00
  • Report 05IK-OHME4860 has a star rating of 4.1 out of 5
  • Go to More information on Report 05IK-OHME4860
  • View Report: Research and Experts Industry Report: Biotechnology in Asia-Pacific

    Biotechnology in Asia-Pacific


    2016-01-18
    Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key...
  • Industry Report
  • Biotechnology
  • Asia Pacific
  • $350.00
  • Report 05IK-OHME5100 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME5100
  • View Report: Research and Experts Industry Report: Biotechnology in Japan

    Biotechnology in Japan


    2016-01-18
    Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Japan
  • $350.00
  • Report 05IK-OHME4829 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME4829
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2016

    Osteoarthritis - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7811IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7811IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2016

    Dyslipidemia - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7652IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7652IDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H1 2016

    Epilepsy - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2016’, provides an overview of the Epilepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7565IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7565IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016

    Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathy (Sensory Neuropathy) clinical trials scenario. This report provides top...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3299CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3299CTIDB
  • View Report: Research and Experts Market Report: Osteosarcoma - Pipeline Review, H1 2016

    Osteosarcoma - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2016’, provides an overview of the Osteosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7808IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7808IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: Fungemia Global Clinical Trials Review, H1, 2016

    Fungemia Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Fungemia Global Clinical Trials Review, H1, 2016" provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3268CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3268CTIDB
  • View Report: Research and Experts Market Report: Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2016

    Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2016" provides an overview of Herpes Zoster (Shingles) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3247CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3247CTIDB
  • View Report: Research and Experts Market Report: Genital Herpes Global Clinical Trials Review, H1, 2016

    Genital Herpes Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3246CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3246CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: B-Cell Non-Hodgkin

    OpportunityAnalyzer: B-Cell Non-Hodgkin's Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen....
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC018POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC018POA
  • View Report: Research and Experts Market Report: Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021<br />
Nanoparticles, Polymers, Liposomes, Micelles,...

    Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021
    Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment


    2016-04-04
    Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021
    Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment
    This newly...

  • Market Report
  • Pharmaceutical Manufacturing
  • Global
  • $3,800.00
  • Report 01B7-2016TarDDR has a star rating of 4.8 out of 5
  • Go to More information on Report 01B7-2016TarDDR
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

    F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME756D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME756D
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2016

    Indolent Lymphoma - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7663IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7663IDB
  • View Report: Research and Experts Market Report: Hyperlipidemia - Pipeline Review, H1 2016

    Hyperlipidemia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hyperlipidemia,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7653IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7653IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H1 2016

    Constipation - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2016’, provides an overview of the Constipation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Constipation, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7594IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7594IDB
  • View Report: Research and Experts Market Report: Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2016

    Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2016’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7584IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7584IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H1 2016

    Diabetic Neuropathic Pain - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7576IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7576IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7562IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7562IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2016

    Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2016’, provides an overview of the Chemotherapy Induced Nausea and Vomiting pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7667IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7667IDB
  • View Report: Research and Experts Market Report: Diabetic Macular Edema - Pipeline Review, H1 2016

    Diabetic Macular Edema - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2016’, provides an overview of the Diabetic Macular Edema pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7647IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7647IDB
  • View Report: Research and Experts Market Report: Urinary Incontinence - Pipeline Review, H1 2016

    Urinary Incontinence - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H1 2016’, provides an overview of the Urinary Incontinence pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Urinary...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7611IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7611IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H1 2016

    Fibromyalgia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2016’, provides an overview of the Fibromyalgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fibromyalgia, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7575IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7575IDB
  • View Report: Research and Experts Market Report: Nocturia - Pipeline Review, H1 2016

    Nocturia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Nocturia - Pipeline Review, H1 2016’, provides an overview of the Nocturia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Nocturia, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7610IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7610IDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H1, 2016

    Venous Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3233CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3233CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H1, 2016

    Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3232CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3232CTIDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis Global Clinical Trials Review, H1, 2016

    Atopic Dermatitis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H1, 2016" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3226CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3226CTIDB
  • View Report: Research and Experts Market Report: Dermatitis Global Clinical Trials Review, H1, 2016

    Dermatitis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H1, 2016" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3225CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3225CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H1, 2016

    Atrial Flutter Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3218CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3218CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023

    OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023


    2015-12-01
    The main drivers of growth in graft versus host disease over the 2013-2023 forecast period include the increasing numbers of allogeneic hematopoietic stem cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM.

    Sa...

  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC014EPOA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC014EPOA
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016

    Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3193CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3193CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2024


    2015-11-03
    Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others...
  • Market Report
  • Healthcare
  • Global
  • $10,995.00
  • Report 05IC-GDHC120PIDR has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC120PIDR
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H2 2015

    Epilepsy - Pipeline Review, H2 2015


    2015-11-11
    Epilepsy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7401IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7401IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H2 2015

    Postherpetic Neuralgia - Pipeline Review, H2 2015


    2015-10-30
    Postherpetic Neuralgia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7240IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7240IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2015

    Osteoarthritis Pain - Pipeline Review, H2 2015


    2015-10-30
    Osteoarthritis Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7221IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7221IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H2 2015

    Overactive Bladder - Pipeline Review, H2 2015


    2015-10-30
    Overactive Bladder - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H2 2015’, provides an overview of the Overactive Bladder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7219IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7219IDB
  • View Report: Research and Experts Market Report: Kidney Transplantation - Pipeline Review, H2 2015

    Kidney Transplantation - Pipeline Review, H2 2015


    2015-10-30
    Kidney Transplantation - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Kidney transplantation - Pipeline Review, H2 2015’, provides an overview of the Kidney transplantation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7291IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7291IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Herpes Zoster (Shingles) - Pipeline Review, H2 2015

    Herpes Zoster (Shingles) - Pipeline Review, H2 2015


    2015-10-28
    Herpes Zoster (Shingles) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H2 2015’, provides an overview of the Herpes Zoster (Shingles)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7271IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7271IDB
  • View Report: Research and Experts Market Report: Drug Addiction - Pipeline Review, H2 2015

    Drug Addiction - Pipeline Review, H2 2015


    2015-10-28
    Drug Addiction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H2 2015’, provides an overview of the Drug Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7225IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7225IDB
  • View Report: Research and Experts Market Report: Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015


    2015-10-21
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015’,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7245IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7245IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2015

    Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2015


    2015-10-21
    Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6852IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6852IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H2 2015

    Endometriosis - Pipeline Review, H2 2015


    2015-10-21
    Endometriosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2015’, provides an overview of the Endometriosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6846IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6846IDB
  • View Report: Research and Experts Market Report: Diabetic Macular Edema - Pipeline Review, H2 2015

    Diabetic Macular Edema - Pipeline Review, H2 2015


    2015-10-21
    Diabetic Macular Edema - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H2 2015’, provides an overview of the Diabetic Macular Edema’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6844IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6844IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015


    2015-10-21
    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6843IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6843IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Diabetic Neuropathic Pain - Pipeline Review, H2 2015


    2015-10-14
    Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6858IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6858IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015


    2015-10-14
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6856IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6856IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Refractory Multiple Myeloma - Pipeline Review, H2 2015


    2015-09-30
    Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7074IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7074IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Herpes Simplex Infections - Pipeline Review, H2 2015

    Herpes Simplex Infections - Pipeline Review, H2 2015


    2015-09-23
    Herpes Simplex Infections - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H2 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7082IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7082IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Visceral Pain - Pipeline Review, H2 2015

    Visceral Pain - Pipeline Review, H2 2015


    2015-09-16
    Visceral Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H2 2015’, provides an overview of the Visceral Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7124IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7124IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2015

    Arterial Thrombosis - Pipeline Review, H2 2015


    2015-09-16
    Arterial Thrombosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7120IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7120IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H2 2015

    T-Cell Leukemia - Pipeline Review, H2 2015


    2015-09-16
    T-Cell Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H2 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7107IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7107IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Gastric Ulcers - Pipeline Review, H2 2015

    Gastric Ulcers - Pipeline Review, H2 2015


    2015-09-09
    Gastric Ulcers - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Ulcers - Pipeline Review, H2 2015’, provides an overview of the Gastric Ulcers’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7139IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7139IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2015

    Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2015


    2015-08-31
    Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2015’, provides an overview of the Chemotherapy Induced Nausea and Vomiting’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6994IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6994IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2015

    Indolent Lymphoma - Pipeline Review, H2 2015


    2015-08-31
    Indolent Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6983IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6983IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Urinary Incontinence - Pipeline Review, H2 2015

    Urinary Incontinence - Pipeline Review, H2 2015


    2015-08-26
    Urinary Incontinence - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H2 2015’, provides an overview of the Urinary Incontinence’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7004IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7004IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2015

    Bladder Cancer - Pipeline Review, H2 2015


    2015-07-31
    Bladder Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6939IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6939IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H2 2015

    Constipation - Pipeline Review, H2 2015


    2015-07-31
    Constipation - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Constipation - Pipeline Review, H2 2015’, provides an overview of the Constipation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6864IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6864IDB
  • View Report: Research and Experts Market Report: High Triglyceridemia - Pipeline Review, H2 2015

    High Triglyceridemia - Pipeline Review, H2 2015


    2015-07-31
    High Triglyceridemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘High Triglyceridemia - Pipeline Review, H2 2015’, provides an overview of the High Triglyceridemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6859IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6859IDB
  • View Report: Research and Experts Market Report: Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015

    Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015


    2015-07-22
    Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6908IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6908IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015


    2015-06-30
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, provides an overview of the Transitional...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6814IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6814IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2015

    Osteoarthritis - Pipeline Review, H1 2015


    2015-06-30
    Osteoarthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6571IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6571IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2015

    Schizophrenia - Pipeline Review, H1 2015


    2015-06-30
    Schizophrenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6568IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6568IDB
  • View Report: Research and Experts Market Report: Thrombosis - Pipeline Review, H1 2015

    Thrombosis - Pipeline Review, H1 2015


    2015-06-30
    Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6511IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6511IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015

    Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015


    2015-06-30
    Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015’, provides an overview of the Respiratory Syncytial Virus...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6574IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6574IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2015

    Osteoporosis - Pipeline Review, H1 2015


    2015-06-30
    Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6572IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6572IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-24
    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Refractory Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6697IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6697IDB
  • View Report: Research and Experts Market Report: Migraine - Pipeline Review, H1 2015

    Migraine - Pipeline Review, H1 2015


    2015-06-24
    Migraine - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Migraine - Pipeline Review, H1 2015’, provides an overview of the Migraine’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6692IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6692IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2015

    Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-24
    Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6681IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6681IDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome - Pipeline Review, H1 2015

    Irritable Bowel Syndrome - Pipeline Review, H1 2015


    2015-06-17
    Irritable Bowel Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2015’, provides an overview of the Irritable Bowel Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6702IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6702IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-17
    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6699IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6699IDB
  • View Report: Research and Experts Market Report: Low Back Pain - Pipeline Review, H1 2015

    Low Back Pain - Pipeline Review, H1 2015


    2015-06-10
    Low Back Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H1 2015’, provides an overview of the Low Back Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6717IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6717IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathy - Pipeline Review, H1 2015

    Diabetic Neuropathy - Pipeline Review, H1 2015


    2015-06-10
    Diabetic Neuropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6713IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6713IDB
  • View Report: Research and Experts Market Report: Aspergillosis - Pipeline Review, H1 2015

    Aspergillosis - Pipeline Review, H1 2015


    2015-06-10
    Aspergillosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H1 2015’, provides an overview of the Aspergillosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6708IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6708IDB
  • View Report: Research and Experts Market Report: Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015

    Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015


    2015-05-29
    Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015’, provides an overview of the Cytomegalovirus (HHV-5) Infections’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6579IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6579IDB
  • View Report: Research and Experts Market Report: Emesis (Vomiting) - Pipeline Review, H1 2015

    Emesis (Vomiting) - Pipeline Review, H1 2015


    2015-05-29
    Emesis (Vomiting) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Emesis (Vomiting) - Pipeline Review, H1 2015’, provides an overview of the Emesis (Vomiting)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6719IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6719IDB
  • View Report: Research and Experts Market Report: Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015

    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015


    2015-05-29
    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2015’, provides an overview of the Chronic Kidney Disease...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6586IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6586IDB
  • View Report: Research and Experts Market Report: Kidney Transplantation - Pipeline Review, H1 2015

    Kidney Transplantation - Pipeline Review, H1 2015


    2015-05-29
    Kidney Transplantation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Transplantation - Pipeline Review, H1 2015’, provides an overview of the Kidney Transplantation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6534IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6534IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2015

    Osteoarthritis Pain - Pipeline Review, H1 2015


    2015-05-29
    Osteoarthritis Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6526IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6526IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H1 2015

    Overactive Bladder - Pipeline Review, H1 2015


    2015-05-29
    Overactive Bladder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2015’, provides an overview of the Overactive Bladder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6525IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6525IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathic Pain - Pipeline Review, H1 2015

    Peripheral Neuropathic Pain - Pipeline Review, H1 2015


    2015-05-20
    Peripheral Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Peripheral Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6747IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6747IDB
  • View Report: Research and Experts Market Report: Hairy Cell Leukemia - Pipeline Review, H1 2015

    Hairy Cell Leukemia - Pipeline Review, H1 2015


    2015-05-20
    Hairy Cell Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the Hairy Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6737IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6737IDB
  • View Report: Research and Experts Market Report: Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015

    Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015


    2015-04-30
    Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015’, provides an overview of the Varicella Zoster (HHV-3) Infections’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6547IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6547IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H1 2015

    Postherpetic Neuralgia - Pipeline Review, H1 2015


    2015-04-30
    Postherpetic Neuralgia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6546IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6546IDB
  • View Report: Research and Experts Market Report: Venous (Vein) Thrombosis - Pipeline Review, H1 2015

    Venous (Vein) Thrombosis - Pipeline Review, H1 2015


    2015-04-29
    Venous (Vein) Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Venous (Vein) Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6609IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6609IDB
  • View Report: Research and Experts Market Report: Liver Transplantation - Pipeline Review, H1 2015

    Liver Transplantation - Pipeline Review, H1 2015


    2015-04-22
    Liver Transplantation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Transplantation - Pipeline Review, H1 2015’, provides an overview of the Liver Transplantation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6634IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6634IDB
  • View Report: Research and Experts Market Report: Heart Transplantation - Pipeline Review, H1 2015

    Heart Transplantation - Pipeline Review, H1 2015


    2015-04-15
    Heart Transplantation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Heart Transplantation - Pipeline Review, H1 2015’, provides an overview of the Heart Transplantation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6659IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6659IDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Relapsed Multiple Myeloma - Pipeline Review, H1 2015


    2015-03-31
    Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6247IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6247IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Herpes Zoster (Shingles) - Pipeline Review, H1 2015

    Herpes Zoster (Shingles) - Pipeline Review, H1 2015


    2015-03-19
    Herpes Zoster (Shingles) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Herpes Zoster (Shingles) - Pipeline Review, H1 2015’, provides an overview of the Herpes Zoster (Shingles)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6433IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6433IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Herpes Simplex Infections - Pipeline Review, H1 2015

    Herpes Simplex Infections - Pipeline Review, H1 2015


    2015-03-11
    Herpes Simplex Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6255IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6255IDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia - Pipeline Review, H1 2015

    Hyperphosphatemia - Pipeline Review, H1 2015


    2015-02-24
    Hyperphosphatemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hyperphosphatemia - Pipeline Review, H1 2015’, provides an overview of the Hyperphosphatemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6283IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6283IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H1 2015

    T-Cell Leukemia - Pipeline Review, H1 2015


    2015-02-24
    T-Cell Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6280IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6280IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015


    2015-02-24
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6271IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6271IDB
  • View Report: Research and Experts Market Report: Gastric Ulcers - Pipeline Review, H1 2015

    Gastric Ulcers - Pipeline Review, H1 2015


    2015-02-18
    Gastric Ulcers - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Ulcers - Pipeline Review, H1 2015’, provides an overview of the Gastric Ulcers’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6313IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6313IDB
  • View Report: Research and Experts Market Report: Visceral Pain - Pipeline Review, H1 2015

    Visceral Pain - Pipeline Review, H1 2015


    2015-02-18
    Visceral Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Visceral Pain - Pipeline Review, H1 2015’, provides an overview of the Visceral Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6298IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6298IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2015

    Arterial Thrombosis - Pipeline Review, H1 2015


    2015-02-18
    Arterial Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6294IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6294IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2015

    Chronic Pain - Pipeline Review, H1 2015


    2015-02-10
    Chronic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2015’, provides an overview of the Chronic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6129IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6129IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H1 2015

    Diabetic Nephropathy - Pipeline Review, H1 2015


    2015-01-30
    Diabetic Nephropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6138IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6138IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Refractory Multiple Myeloma - Pipeline Review, H1 2015


    2015-01-30
    Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6135IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6135IDB
  • View Report: Research and Experts Market Report: Women Infertility - Pipeline Review, H1 2015

    Women Infertility - Pipeline Review, H1 2015


    2015-01-30
    Women Infertility - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2015’, provides an overview of the Women Infertility’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6133IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6133IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015


    2015-01-30
    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015’, provides an overview of the Chronic Obstructive Pulmonary...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6009IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6009IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Urinary Incontinence - Pipeline Review, H1 2015

    Urinary Incontinence - Pipeline Review, H1 2015


    2015-01-30
    Urinary Incontinence - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Urinary Incontinence - Pipeline Review, H1 2015’, provides an overview of the Urinary Incontinence’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6182IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6182IDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism - Pipeline Review, H1 2015

    Secondary Hyperparathyroidism - Pipeline Review, H1 2015


    2015-01-30
    Secondary Hyperparathyroidism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H1 2015’, provides an overview of the Secondary Hyperparathyroidism’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6174IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6174IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2015

    Indolent Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Indolent Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6162IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6162IDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H1 2015

    Epilepsy - Pipeline Review, H1 2015


    2015-01-30
    Epilepsy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6014IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6014IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-01-30
    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6012IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6012IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2015

    Peritoneal Cancer - Pipeline Review, H1 2015


    2015-01-22
    Peritoneal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6120IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6120IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2015

    Ulcerative Colitis - Pipeline Review, H1 2015


    2015-01-22
    Ulcerative Colitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2015’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6015IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6015IDB
  • View Report: Research and Experts Market Report: Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015

    Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015


    2015-01-22
    Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6094IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6094IDB
  • View Report: Research and Experts Market Report: Myasthenia Gravis - Pipeline Review, H1 2015

    Myasthenia Gravis - Pipeline Review, H1 2015


    2015-01-22
    Myasthenia Gravis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6062IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6062IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H1 2015

    Constipation - Pipeline Review, H1 2015


    2015-01-22
    Constipation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2015’, provides an overview of the Constipation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6050IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6050IDB
  • View Report: Research and Experts Market Report: High Triglyceridemia - Pipeline Review, H1 2015

    High Triglyceridemia - Pipeline Review, H1 2015


    2015-01-22
    High Triglyceridemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘High Triglyceridemia - Pipeline Review, H1 2015’, provides an overview of the High Triglyceridemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6045IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6045IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H1 2015

    Diabetic Neuropathic Pain - Pipeline Review, H1 2015


    2015-01-22
    Diabetic Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6044IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6044IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H1 2015

    Endometriosis - Pipeline Review, H1 2015


    2015-01-22
    Endometriosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2015’, provides an overview of the Endometriosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6032IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6032IDB
  • View Report: Research and Experts Market Report: Diabetic Macular Edema - Pipeline Review, H1 2015

    Diabetic Macular Edema - Pipeline Review, H1 2015


    2015-01-22
    Diabetic Macular Edema - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H1 2015’, provides an overview of the Diabetic Macular Edema’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6030IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6030IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6029IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6029IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2015

    Asthma - Pipeline Review, H1 2015


    2015-01-22
    Asthma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6007IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6007IDB
  • View Report: Research and Experts Company Report: Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review

    Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review


    2016-03-22
    Otsuka Holdings Co., Ltd. (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture,...
  • Company Report
  • Life Sciences
  • Japan
  • $300.00
  • Report 05IC-GDPH219028FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH219028FSA
  • View Report: Research and Experts Company Report: Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review

    Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review


    2016-09-07
    Daiichi Sankyo Company, Limited (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs,...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH5751FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH5751FSA
  • View Report: Research and Experts Company Report: Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review

    Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Kobayashi Pharmaceutical Co., Ltd. (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, sanitary products, household...
  • Company Report
  • Life Sciences
  • Japan
  • $300.00
  • Report 05IC-GDPH34412FSA has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDPH34412FSA
  • View Report: Research and Experts Company Report: Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review

    Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Nippon Kayaku Co., Ltd. (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company's product portfolio includes epoxy resins, UV-curing...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH31776FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH31776FSA
  • View Report: Research and Experts Company Report: Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review

    Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Takeda Pharmaceutical Company Limited (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH7835FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH7835FSA
  • View Report: Research and Experts Company Report: CTI BioPharma Corp. (CTIC) - Financial and Strategic SWOT Analysis Review

    CTI BioPharma Corp. (CTIC) - Financial and Strategic SWOT Analysis Review


    2016-06-07
    CTI BioPharma Corp. (CTI BioPharma), formerly Cell Therapeutics, Inc., is a biopharmaceutical company which acquires, develops, and commercializes targeted therapies for the treatment of a range of blood-related cancers. The company’s lead product,...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH34546FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH34546FSA
  • View Report: Research and Experts Company Report: Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

    Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH27458FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH27458FSA
  • View Report: Research and Experts Company Report: Emisphere Technologies, Inc. (EMIS) - Financial and Strategic SWOT Analysis Review

    Emisphere Technologies, Inc. (EMIS) - Financial and Strategic SWOT Analysis Review


    2016-05-17
    Emisphere Technologies, Inc. (Emisphere) is commercial stage specialty pharmaceutical company. It partners with global pharmaceutical companies for the development of new orally delivered therapeutics. The company focuses on developing new formulations...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH81610FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH81610FSA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Financial and Strategic SWOT Analysis Review

    F. Hoffmann-La Roche Ltd. (ROG) - Financial and Strategic SWOT Analysis Review


    2016-10-12
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company that provides biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its products include medicines to treat cancers, brain diseases, viral and bacterial...
  • Company Report
  • Life Sciences
  • Switzerland
  • $125.00
  • Report 05IC-GDPH756FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH756FSA
  • View Report: Research and Experts Market Report: Psoriasis Global Clinical Trials Review, H2, 2015

    Psoriasis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H2, 2015" provides an overview of Psoriasis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3000CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3000CTIDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015

    Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hyperphosphatemia In Chronic Kidney Disease clinical trials scenario. This report provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2993CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC2993CTIDB
  • View Report: Research and Experts Market Report: Muscle Wasting Disorders Global Clinical Trials Review, H2, 2015

    Muscle Wasting Disorders Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Muscle Wasting Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Muscle Wasting Disorders clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2968CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC2968CTIDB
  • View Report: Research and Experts Market Report: Nocturia Global Clinical Trials Review, H2, 2015

    Nocturia Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Nocturia Global Clinical Trials Review, H2, 2015" provides an overview of Nocturia clinical trials scenario. This report provides top line data relating to the clinical trials on Nocturia. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2957CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC2957CTIDB
  • View Report: Research and Experts Market Report: Ovarian Disease Global Clinical Trials Review, H2, 2015

    Ovarian Disease Global Clinical Trials Review, H2, 2015


    2015-12-04
    GlobalData's clinical trial report, “Ovarian Disease Global Clinical Trials Review, H2, 2015" provides an overview of Ovarian Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3033CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3033CTIDB
  • View Report: Research and Experts Market Report: Eczema Global Clinical Trials Review, H2, 2015

    Eczema Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Eczema Global Clinical Trials Review, H2, 2015" provides an overview of Eczema clinical trials scenario. This report provides top line data relating to the clinical trials on Eczema. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3008CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3008CTIDB
  • View Report: Research and Experts Company Report: Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

    Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


    2012-02-02
    ICD Research's "Astellas Pharma Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business...
  • Company Report
  • Pharmaceuticals
  • Japan
  • $125.00
  • Report 01H3-ST01043CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-ST01043CP
  • Industries and Sectors

    • Healthcare (21)
    • Pharmaceuticals (145)
    • Dermatology (4)
    • Infectious Disease... (8)
    • Oncology (49)
    • Immunology (14)
    • Gastrointestinal... (11)
    • Central Nervous... (16)
    • Cardiovascular (7)
    • Genitourinary Disorders... (3)
    • Biotechnology (7)
    • Life Sciences (102)
    • Metabolic Disorders... (4)
    • Unassigned (8)
    • Respiratory (2)
    • Iron and steel Construction... (23)
    • Pharmaceutical Manufacturing... (1)
    • Medical Devices (1)

    Geographic Regions

    • Global (405)
    • Asia Pacific (4)
    • Japan (12)
    • Singapore (1)
    • Switzerland (2)
    • United States (2)

    Report Types

    • Market Report (405)
    • Industry Report (9)
    • Project Profile (1)
    • Company Report (11)

    Return to Company List

    Page created and rendered - Cache updated [3.75764s]